Safety
-
Ultane and Ultane NovaPlus (Sevoflurane) Volatile Liquid for Inhalation
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – August 2012
WARNINGS
- e.g., patients with congenital Long QT Syndrome or patients taking drugs that can prolong the QT interval).
-
-







